EDRH
NVCR icon

Edmond de Rothschild Holding’s NovoCure NVCR Stock Holding History

Edmond de Rothschild Holding’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-700
Closed -$81K – 882
2021
Q3 		$81K Buy
+700
New +$106K ﹤0.01% 651
2020
Q4 		– Sell
-993
Closed -$111K – 666
2020
Q3 		$111K Buy
+993
New +$79.4K ﹤0.01% 457

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edmond de Rothschild Holding's NVCR Position: Q4 2021 in Review

Edmond de Rothschild Holding sold out of NovoCure (NVCR) in Q4 2021, closing a stake of 700 shares — an estimated $81K sold.

Edmond de Rothschild Holding first reported a position in NVCR in Q3 2020 and held it in 2 quarters. The position peaked at $111K in Q3 2020. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • Edmond de Rothschild Holding reported no remaining NovoCure position as of Q4 2021 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 700 NovoCure shares in Q4 2021, an estimated $81K.
  • Edmond de Rothschild Holding first reported a position in NovoCure in Q3 2020 and held it in 2 quarters.
  • Edmond de Rothschild Holding's NovoCure position peaked at $111K in Q3 2020.
  • 311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2021, filed 10 Feb 2022.